View More Recent Stories

Dec 11, 2024 05:13AM Citi Upgrades Glaukos Corporation (GKOS) to Buy
Dec 6, 2024 03:47AM UBS Starts Glaukos Corporation (GKOS) at Buy
Dec 2, 2024 07:52AM Glaukos Corporation (GKOS) PT Raised to $153 at Stifel
Dec 2, 2024 06:26AM Morgan Stanley Downgrades Glaukos Corporation (GKOS) to Underweight
Nov 5, 2024 07:14AM Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)
Nov 5, 2024 06:08AM Needham Reiterates Buy Rating on Glaukos Corporation (GKOS)
Nov 5, 2024 05:12AM Glaukos Corporation (GKOS) PT Raised to $140 at BTIG
Nov 4, 2024 04:15PM Glaukos Corporation (GKOS) Tops Q3 EPS by 20c, provides guidance
Oct 29, 2024 06:09AM Glaukos Corporation (GKOS) PT Raised to $155 at Jefferies
Oct 21, 2024 08:34AM Truist Securities Reiterates Buy Rating on Glaukos Corporation (GKOS)
Oct 17, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)
Oct 16, 2024 04:05PM Glaukos Corporation (GKOS) Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa
Sep 26, 2024 07:56AM BTIG Reiterates Buy Rating on Glaukos Corporation (GKOS)
Sep 23, 2024 05:09AM BTIG Reiterates Buy Rating on Glaukos Corporation (GKOS)
Sep 3, 2024 08:17AM Glaukos Corporation (GKOS) PT Raised to $145 at Stifel
Aug 1, 2024 07:42AM Glaukos Corporation (GKOS) PT Raised to $140 at Piper Sandler
Aug 1, 2024 07:22AM Glaukos Corporation (GKOS) PT Raised to $137 at Needham
Aug 1, 2024 06:05AM Glaukos Corporation (GKOS) PT Raised to $145 at Truist Securities
Jul 31, 2024 04:29PM Glaukos Corporation (GKOS) Reports In-Line Q2 EPS, Beats on Revenue; Offers FY24 Revenue Guidance
Jul 16, 2024 07:06AM Glaukos Corporation (GKOS) PT Raised to $141 at Truist Securities
Jul 15, 2024 06:38AM Glaukos Corporation (GKOS) PT Raised to $115 at Mizuho
Jul 15, 2024 04:00AM MedTech stocks: Q2 earnings season preview
Jun 14, 2024 07:01AM Glaukos Corporation (GKOS) to Exchange $230M in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
Apr 13, 2024 08:00AM Analyst weighs in on current investor sentiment in MedTech sector
View More Recent Stories